? Research Education Core (REC) The overall mission of the Research Education Core (REC) will be to create the diverse human resources capable of conducting team-based interdisciplinary research focused on addressing the complex problems posed by chemical agents. Advanced training in basic and translational sciences, toxicology, and drug discovery will be provided to the next generation of researchers, more specifically, technicians, medical and graduate students, postdoctoral fellows, and/or early stage investigators within and outside the UC Davis CounterACT Center. Accordingly, the REC will interact with all cores and projects of the Center. The educational environment at UC Davis is unique. UC Davis is a national leader in pharmacology and toxicology with over 100 faculty whose expertise includes fundamental toxicology, medicinal chemistry, drug screening, mechanistic target identification, animal models of disease, as well as preclinical testing and participation in clinical trials. The great depth and breadth of campus activities are reflected in the expertise found in the Center investigators. The training of future leaders in the development of medical countermeasures for chemical threat agents is critical to the success of the CounterACT program and to national emergency response and preparedness efforts. The REC will focus on three main objectives to accomplish this goal. Objective 1 will develop skill sets necessary for the study of toxicology and drug discovery related to chemical threat agents. First, hands- on interdisciplinary and collaborative research training primarily in the laboratories of the project and core leaders will be provided. Second, specialized didactic training in areas relevant to the Center's mission will be accomplished by presenting information via workshops, seminars, and specialized coursework. Objective 2 will enhance the recruitment of participants from underrepresented backgrounds into the CounterACT Center of Excellence in particular, and in toxicology and drug discovery in general. Objective 3 will evaluate the activities of the Core to assess effectiveness and identify areas for improvement. The REC will advance the knowledge and careers of Center trainees by providing opportunities to interact with and learn from both internal and external scientists with expertise relevant to the CounterACT mission. By fulfilling these aims, the REC will accomplish its goal of developing a diverse group of scientists with broader understanding of the concepts, challenges, and opportunities in drug discovery and development of medical countermeasures of chemical threats.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS079202-06
Application #
9352467
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2017-09-01
Budget End
2018-05-31
Support Year
6
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Hampe, Alexander E; Li, Zidong; Sethi, Sunjay et al. (2018) A Microfluidic Platform to Study Astrocyte Adhesion on Nanoporous Gold Thin Films. Nanomaterials (Basel) 8:
Hobson, Brad A; Rowland, Douglas J; Supasai, Suangsuda et al. (2018) A magnetic resonance imaging study of early brain injury in a rat model of acute DFP intoxication. Neurotoxicology 66:170-178
Moeller, Benjamin; Espelien, Brenna; Weber, Waylon et al. (2018) The pharmacokinetics of ketamine following intramuscular injection to F344 rats. Drug Test Anal :
Pressly, Brandon; Nguyen, Hai M; Wulff, Heike (2018) GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS. Arch Toxicol 92:833-844
Dhir, Ashish; Rogawski, Michael A (2018) Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. Epilepsia 59:935-944
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279
Nik, Atefeh Mousavi; Pressly, Brandon; Singh, Vikrant et al. (2017) Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye. Mol Pharmacol 92:88-99
Zhou, Yong; Liu, Tian; Duan, Jia-Xi et al. (2017) Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice. Shock 47:638-645
Barnych, Bogdan; Vasylieva, Natalia; Joseph, Tom et al. (2017) Development of Tetramethylenedisulfotetramine (TETS) Hapten Library: Synthesis, Electrophysiological Studies, and Immune Response in Rabbits. Chemistry 23:8466-8472
Chapman, Christopher A R; Wang, Ling; Chen, Hao et al. (2017) Nanoporous Gold Biointerfaces: Modifying Nanostructure to Control Neural Cell Coverage and Enhance Electrophysiological Recording Performance. Adv Funct Mater 27:

Showing the most recent 10 out of 85 publications